Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

This publication has 21 references indexed in Scilit:

• The three-month recurrence as a prognostic factor for the long term outcome in TaT1 bladder cancer
  European Journal Of Cancer, 1999
• Significance of Bladder Biopsies in Ta,T1 Bladder Tumors: A Report from the EORTC Genito-Urinary Tract Cancer Cooperative Group
  European Urology, 1999
• Long-term follow-up of an EORTC randomized prospective trial comparing intravesical bacille calmette-guérin–RIVM and mitomycin c in superficial bladder cancer
  Urology, 1998
• A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer
  Journal of Urology, 1996
• Factors affecting recurrence and progression in superficial bladder tumours
  European Journal Of Cancer, 1995
• Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term Treatment
  Journal of Urology, 1995
• Histopathological “Self Control” in Transurethral Resection of Bladder Tumours
  British Journal of Urology, 1991
• Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)
  BMJ, 1988
• Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder Carcinoma
  British Journal of Urology, 1976
• Susceptibility of urothelium to neoplastic cellular implantation
  Urology, 1975